DocuSign (DOCU) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

DocuSign’s first quarter results surpassed Wall Street’s revenue and profit expectations, yet the market reacted negatively due to concerns around billings growth and the timing of early renewals.

An uninspiring quarterly earnings report and a clutch of analyst price target cuts put Docusign (NASDAQ: DOCU) stock in the market's doghouse in June. Before the first trading week of the month ...

DocuSign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating ...

DocuSign, Inc. DOCU reported impressive first-quarter fiscal 2026 results, wherein earnings per share (EPS) and revenues surpassed the Zacks Consensus Estimate. However, the better-than-expected ...

SAN FRANCISCO, May 16, 2024 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its first quarter fiscal 2025 results will be released on Thursday, June 6, 2024, after the close of the ...

Finally, Wedbush decreased their price objective on Docusign from $100.00 to $85.00 and set a “neutral” rating on the stock in a report on Thursday, June 12th.

DocuSign Q1 results (DocuSign Q1 earnings deck) DocuSign's revenue grew 7.6% y/y to $763.7 million, beating Wall Street's much more conservative $749.0 million (+5.6% y/y) expectations by a two ...

Docusign, Inc. DOCU has been under considerable selling pressure, with the stock declining 15.4% year to date. This drop is in stark contrast to the 14% rally in its industry and the 6% gain in the ...

Docusign's stock trades at 61 times forward earnings and 5 times this year's sales. Confluent can't be valued by its profits, but it trades at 7 times this year's sales.